Entropy Technologies, LP Crinetics Pharmaceuticals, Inc. Transaction History

Entropy Technologies, LP

  • $971 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$42.12 - $51.91 $46,163 - $56,893
-1,096 Reduced 10.08%
9,782 $438 Million
Q1 2024

May 08, 2024
SELL
$34.76 - $46.81 $956,108 - $1.29 Million
-27,506 Reduced 71.66%
10,878 $509 Million
Q4 2023

Feb 14, 2024
BUY
$25.62 - $37.07 $983,398 - $1.42 Million
38,384 New
38,384 $1.37 Billion

Others Institutions Holding CRNX

# of Institutions
254
Shares Held
82.5M
Call Options Held
26.1K
Put Options Held
11.8K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $1.89B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email